Valneva Austria Gmbh
Pharmaceutical company working on the research, development, and manufacture of vaccines.
🤖
AI Overview
With $680K in lobbying spend across 18 quarterly filings, Valneva Austria Gmbh is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2022.
$680K
Total Spend
5
Years Active
1
Firms Hired
3
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $10K |
| 2019 | $160K |
| 2020 | $180K |
| 2021 | $170K |
| 2022 | $160K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Pharmacy, MED, Health Issues
- •Issues related to the prevention and treatment of tick-born illness, including Lyme Disease
- •Advocating for R&D funding for Lyme Disease vaccine programs
- •FY2020 Labor-HHS-Education Appropriations Related to the research and development of Lyme Disease vaccine programs within the Department of Health and Human Services/NIAID.
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.